Streptococcus equi antigens adsorbed onto surface modified poly-ε-caprolactone microspheres induce humoral and cellular specific immune responses

被引:39
作者
Florindo, H. F. [2 ]
Pandit, S. [2 ]
Goncalves, L. M. D. [3 ]
Alpar, H. O. [2 ]
Almeida, A. J. [1 ]
机构
[1] Univ Lisbon, Fac Farm, Dept Tecnol Farmaceut, iMED, P-1649003 Lisbon, Portugal
[2] Univ London, Sch Pharm, CDDR, London WC1N 1AX, England
[3] Inst Biol Expt & Tecnol, Unidad Piloto, P-2781901 Oeiras, Portugal
关键词
poly-epsilon-caprolactone microspheres; Streptococcus equi; vaccine adjuvant;
D O I
10.1016/j.vaccine.2008.05.074
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Streptococcus equi subsp. equi is the causative agent of Strangles, which is one of the most costly and widespread infectious diseases, affecting the respiratory tract of Equidae. In this work, polyvinyl alcohol, alginate and chitosan were used in formulations of surface modified poly-epsilon-caprolactone microspheres which were evaluated after adsorption of S. equi enzymatic extract for physicochemical characteristics and in vivo immune responses in mice. After subcutaneous immunisation, the formulations induced higher lymphokines levels, in accordance with cellular and humoral immune responses, as compared to the free antigen, successfully activating the paths leading to Th1 and Th2 cells. The obtained results highlight the role of these microspheres as an adjuvant and their use to protect animals against strangles. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4168 / 4177
页数:10
相关论文
共 49 条
[1]  
ALMEIDA AJ, 1997, ANTIGEN DELIVERY SYS, P207
[2]  
ALPAR HO, 1994, EUR J PHARM BIOPHARM, V40, P198
[3]   Intranasal vaccination against plague, tetanus and diphtheria [J].
Alpar, HO ;
Eyles, JE ;
Williamson, ED ;
Somavarapu, S .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 51 (1-3) :173-201
[4]   Dynamic behavior of adsorber membranes for protein recovery [J].
Avramescu, ME ;
Borneman, Z ;
Wessling, M .
BIOTECHNOLOGY AND BIOENGINEERING, 2003, 84 (05) :564-572
[5]   Microencapsulation of Streptococcus equi antigens in biodegradable microspheres and preliminary immunisation studies [J].
Azevedo, Ana F. ;
Galhardas, Jorge ;
Cunha, Antonio ;
Cruz, Patricia ;
Goncalves, Lidia M. D. ;
Almeida, Antonio J. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 64 (02) :131-137
[6]   Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen [J].
Baras, B ;
Benoit, MA ;
Dupré, L ;
Poulain-Godefroy, O ;
Schacht, AM ;
Capron, A ;
Gillard, J ;
Riveau, G .
INFECTION AND IMMUNITY, 1999, 67 (05) :2643-2648
[7]  
Baras B, 2000, J MICROENCAPSUL, V17, P485
[8]   Preparation and characterization of protein-loaded poly(ε-caprolactone) microparticles for oral vaccine delivery [J].
Benoit, MA ;
Baras, B ;
Gillard, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 184 (01) :73-84
[9]   Particulate delivery systems for vaccines: what can we expect? [J].
Bramwell, Vincent W. ;
Perrie, Yvonne .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (06) :717-728
[10]   Overview of new vaccines and technologies [J].
Chalmers, W. S. K. .
VETERINARY MICROBIOLOGY, 2006, 117 (01) :25-31